Hawkins [HWKN] vs Sherwin-Williams [SHW] Detailed Stock Comparison
Hawkins
NASDAQ
Loading...
Sherwin-Williams
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Hawkins wins in 7 metrics, Sherwin-Williams wins in 13 metrics, with 0 ties. Sherwin-Williams appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Hawkins | Sherwin-Williams | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 42.35 | 36.39 | Sherwin-Williams |
| Price-to-Book Ratio | 7.33 | 20.70 | Hawkins |
| Debt-to-Equity Ratio | 63.70 | 308.57 | Hawkins |
| PEG Ratio | 29.43 | -2.53 | Sherwin-Williams |
| EV/EBITDA | 23.68 | 23.77 | Hawkins |
| Profit Margin (TTM) | 8.37% | 11.03% | Sherwin-Williams |
| Operating Margin (TTM) | 14.09% | 17.46% | Sherwin-Williams |
| EBITDA Margin (TTM) | 14.09% | 17.46% | Sherwin-Williams |
| Return on Equity | 18.69% | 62.43% | Sherwin-Williams |
| Return on Assets (TTM) | 8.92% | 9.34% | Sherwin-Williams |
| Free Cash Flow (TTM) | $70.00M | $2.08B | Sherwin-Williams |
| Dividend Yield | 0.57% | 0.67% | Sherwin-Williams |
| 1-Year Return | 34.28% | 1.43% | Hawkins |
| Price-to-Sales Ratio (TTM) | 3.54 | 3.96 | Hawkins |
| Enterprise Value | $3.87B | $102.44B | Sherwin-Williams |
| EV/Revenue Ratio | 3.83 | 4.44 | Hawkins |
| Gross Profit Margin (TTM) | 24.67% | 49.38% | Sherwin-Williams |
| Revenue per Share (TTM) | $49 | $92 | Sherwin-Williams |
| Earnings per Share (Diluted) | $4.05 | $10.08 | Sherwin-Williams |
| Beta (Stock Volatility) | 0.81 | 1.16 | Hawkins |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Hawkins vs Sherwin-Williams Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Hawkins | 1.15% | -2.44% | 5.22% | 32.34% | 60.99% | 39.41% |
| Sherwin-Williams | 2.53% | -0.47% | 6.61% | 2.80% | 5.60% | 9.21% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Hawkins | 34.28% | 304.74% | 555.07% | 800.32% | 965.88% | 2,486.00% |
| Sherwin-Williams | 1.43% | 54.37% | 61.50% | 322.90% | 1,454.29% | 2,301.72% |
Performance & Financial Health Analysis: Hawkins vs Sherwin-Williams
| Metric | HWKN | SHW |
|---|---|---|
| Market Information | ||
| Market Cap | $3.58B | $91.45B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 211,420 | 1,981,693 |
| 90 Day Avg. Volume | 219,587 | 1,943,951 |
| Last Close | $170.03 | $373.08 |
| 52 Week Range | $98.30 - $185.50 | $308.84 - $400.42 |
| % from 52W High | -8.34% | -6.83% |
| All-Time High | $185.16 (Aug 12, 2025) | $400.42 (Nov 25, 2024) |
| % from All-Time High | -8.17% | -6.83% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.01% |
| Quarterly Earnings Growth | 0.01% | -0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.08% | 0.11% |
| Operating Margin (TTM) | 0.14% | 0.17% |
| Return on Equity (TTM) | 0.19% | 0.62% |
| Debt to Equity (MRQ) | 63.70 | 308.57 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $23.39 | $17.72 |
| Cash per Share (MRQ) | $0.70 | $1.10 |
| Operating Cash Flow (TTM) | $125.00M | $3.06B |
| Levered Free Cash Flow (TTM) | $63.02M | $1.78B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.57% | 0.67% |
| Last 12-Month Dividend | $0.91 | $2.21 |
Valuation & Enterprise Metrics Analysis: Hawkins vs Sherwin-Williams
| Metric | HWKN | SHW |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 42.35 | 36.39 |
| Forward P/E | 40.16 | 28.70 |
| PEG Ratio | 29.43 | -2.53 |
| Price to Sales (TTM) | 3.54 | 3.96 |
| Price to Book (MRQ) | 7.33 | 20.70 |
| Market Capitalization | ||
| Market Capitalization | $3.58B | $91.45B |
| Enterprise Value | $3.87B | $102.44B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.83 | 4.44 |
| Enterprise to EBITDA | 23.68 | 23.77 |
| Risk & Other Metrics | ||
| Beta | 0.81 | 1.16 |
| Book Value per Share (MRQ) | $23.39 | $17.72 |
Financial Statements Comparison: Hawkins vs Sherwin-Williams
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HWKN | SHW |
|---|---|---|
| Revenue/Sales | $245.32M | $6.31B |
| Cost of Goods Sold | $193.08M | $3.20B |
| Gross Profit | $52.24M | $3.12B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $24.58M | $1.10B |
| EBITDA | $34.53M | $1.27B |
| Pre-Tax Income | $22.42M | $985.70M |
| Income Tax | $6.10M | $231.00M |
| Net Income (Profit) | $16.33M | $754.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HWKN | SHW |
|---|---|---|
| Cash & Equivalents | $5.10M | $199.80M |
| Total Current Assets | $230.69M | $6.04B |
| Total Current Liabilities | $107.14M | $7.88B |
| Long-Term Debt | $149.83M | $9.40B |
| Total Shareholders Equity | $460.29M | $4.13B |
| Retained Earnings | $434.26M | $7.55B |
| Property, Plant & Equipment | $13.45M | $1.97B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HWKN | SHW |
|---|---|---|
| Operating Cash Flow | $27.00M | $-86.60M |
| Capital Expenditures | $-11.09M | N/A |
| Free Cash Flow | $19.76M | $-250.40M |
| Debt Repayment | $-10.00M | $-250.00M |
| Common Stock Repurchase | $-14.07M | $-351.70M |
Short Interest & Institutional Ownership Analysis
| Metric | HWKN | SHW |
|---|---|---|
| Shares Short | 1.02M | 3.30M |
| Short Ratio | 4.60 | 1.86 |
| Short % of Float | 0.06% | 0.01% |
| Average Daily Volume (10 Day) | 211,420 | 1,981,693 |
| Average Daily Volume (90 Day) | 219,587 | 1,943,951 |
| Shares Outstanding | 20.68M | 251.29M |
| Float Shares | 19.12M | 229.92M |
| % Held by Insiders | 0.08% | 0.07% |
| % Held by Institutions | 0.73% | 0.84% |
Dividend Analysis & Yield Comparison: Hawkins vs Sherwin-Williams
| Metric | HWKN | SHW |
|---|---|---|
| Last 12-Month Dividend | $0.91 | $2.21 |
| Last 12-Month Dividend Yield | 0.57% | 0.67% |
| 3-Year Avg Annual Dividend | $0.71 | $2.21 |
| 3-Year Avg Dividend Yield | 0.23% | 0.23% |
| 3-Year Total Dividends | $2.13 | $6.63 |
| Ex-Dividend Date | Aug 15, 2025 | Mar 03, 2025 |